 OUTLINE: This is a randomized, open-label, controlled, multicenter study. Patients are stratified according to FIGO stage I-IIA vs IIB-IIIC and tumor no greater than 10 mm vs IIB-IIIC and tumor greater than 10 mm or IV, plan for interval surgical debulking yes vs no, and participating center. Patients are randomized to 1 of 2 treatment arms. 